MedTrace Logo

Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer

NCT05370716 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2022-05-31

No results posted yet for this study

Summary

This is randomized , open-label, multiple-dose, parallel study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG-651" in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Polmacoxib

Polmacoxib

DRUG

Pregabalin

Pregabalin

Sponsors & Collaborators

  • CrystalGenomics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-11
Primary Completion
2020-04-30
Completion
2020-05-19

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05370716 on ClinicalTrials.gov